July 13, 2024
Presentations: Webinar Exploring the Potential of human Platelet Lysate
Download
Working Groups
We are pleased to share the highlights from our recent webinar on the applications and advancements of human platelet lysate, presented by the European Blood Alliance’s Working Group on Innovation and New Products. Held on June 6, 2024 from 13:00 to 14:30 CEST, the session looked into the significant role that human platelet lysate plays in modern medical practices and research.
The event featured expert insights from leaders in the field, including Ólafur Eysteinn Sigurjónsson, Hendrik Feys, Katharina Schallmoser, Erja Kerkelä, and David Lundy. Topics covered the standardization of human platelet lysate, regulatory considerations, good manufacturing practices for advanced therapy medicinal product (ATMP) manufacturing, and innovative treatments for hypoxic injuries.
We were delighted to host 122 attendees from 27 countries who participated in a series of keynote presentations, followed by a panel discussion and an interactive Q&A session. This webinar was particularly beneficial for medical researchers, clinical practitioners, and regulatory affairs professionals keen to engage with the latest developments across various medical domains.
Presentations are now available for those who wish to revisit the material or were unable to attend.
If you would like to watch the recording of the webinar, it is available with registration, by clicking here.
| 13:00 | Opening
Peter O’Leary, Executive Director European Blood Alliance |
| 13:05 | Introduction
Ólafur Eysteinn Sigurjónsson, Head of Research and Development, Icelandic Blood Bank and Chair of EBA Innovation and New Products Working Group |
| 13:15 | Keynote Presentations |
| Towards standardized human Platelet Lysate
Hendrik Feys, Principal Investigator, Red Cross Flanders |
|
| Regulatory aspects
Katharina Schallmoser, Professor for Transfusion Medicine, Paracelsus Medical University of Salzburg, Austria |
|
| Example of GMP production for ATMP manufacturing
Erja Kerkelä, Development Manager, Finnish Red Cross Blood Service |
|
| Treatment of hypoxic injuries
David Lundy, Associate Professor, Taipei Medical University |
|
| 14:15 | Panel Discussion and Q&A |
| Q&A session, allowing participants to engage directly with the experts | |
| 14:35 | Closing
Ólafur Eysteinn Sigurjónsson, Chair Innovation and New Products Working Group |
Download Presentations
